The Results of the HPV Vaccine are Encouraging
A study released in the June issue of The Journal of Infectious Diseases showed that the vaccine against the human papillomavirus has decreased prevalence of the cancer-causing virus among teenage girls by 56 percent, despite being available since only 2006.
The human papillomavirus (HPV), which is sexually transmitted, can cause genital warts, cervical cancer and throat cancer. The CDC recommends that all girls get the vaccine at age 11 or 12 to protect them against cancers that can appear 30 years later.
About 79 million Americans, most in their late teens and early 20s, are infected with HPV. Each year, about 14 million people become newly infected. About 19,000 women in the United States get cancer caused by HPV each year, cervical cancer being the most common.
The study used data from the National Health and Nutrition Examination Survey to compare the proportion of girls and women 14-59 who had certain types of HPV before and after the vaccination program began. Rates in young women infected with the virus dropped 56 percent from the period 2003-06 to 2007-10.You can read more about this here.